What inhaled medication is typically administered for treating bronchospasm during anaphylaxis?

Albuterol is a bronchodilator commonly used to relieve bronchospasm associated with conditions such as asthma and chronic obstructive pulmonary disease (COPD). During anaphylaxis, bronchospasm can occur as part of the body's severe allergic reaction; thus, the administration of albuterol helps alleviate constriction of the airways, leading to improved airflow and breathing.

Albuterol works by stimulating beta-2 adrenergic receptors in the lungs, causing smooth muscle relaxation and subsequent dilation of the airways. This effect is crucial in managing respiratory distress during anaphylaxis, where airway swelling and constriction can significantly impact a patient's ability to breathe.

In this context, other options do not serve the role of directly addressing bronchospasm. For example, atropine is an anticholinergic that primarily helps with bradycardia and does not have specific bronchodilator effects. Furosemide is a diuretic used primarily for fluid overload and has no direct impact on bronchospasm. Dexamethasone is a corticosteroid that helps reduce inflammation but takes time to exert its effects and does not immediately open airways like albuterol does. Therefore, albuterol is the medication of choice for treating bronchospasm during anaphylaxis